Pharmaceutical company MSD sells Oss factory to Organon, 200 jobs lost

Pharmaceutical company MSD is selling its factory in Oss to fellow industry player Organon. The takeover will relocate 295 functions, but will also result in the loss of 200 jobs. Both companies confirmed this after reporting by local media outlet DTV Nieuws. The management of both companies informed the staff of the MSD factory on Tuesday.

The MSD Biotech factory in Oss is being sold to Organon. It is expected that 295 positions will be transferred to that company, but 200 jobs will also be lost. The employees were informed on Tuesday. This was reported by Dtv Nieuws. MSD is trying to place as many people as possible elsewhere in the company or will help staff find a job elsewhere. Last year it was already announced that MSD would close the factory in Oss on 1 July 2025. The produ…